Tenolam E Tablet is a combination of three HIV medications: efavirenz (600 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg), and it is used to treat HIV-1 infection in adults and teenagers.
| Composition | Efavirenz 600mg + Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300 mg |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Hertab contains Lapatinib 250mg, a targeted cancer therapy used in the treatment of HER2-positive breast cancer. It works by blocking specific proteins (HER2 and EGFR) that promote the growth of cancer cells, thereby slowing or stopping tumor progression.
| Composition | Lapatinib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 30 Tablets |
| Prescribed For | Breast Cancers |
| Expiry | December 2027 |
Ledifos is a combination of Ledipasvir (90mg) and Sofosbuvir (400mg), used for the treatment of chronic Hepatitis C virus (HCV) infection.
| Composition | Ledipasvir (90mg) and Sofosbuvir (400mg) |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 28 Tablets in a Bottle |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Nitib contains Ibrutinib 140mg, a targeted therapy used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia.
| Composition | Ibrutinib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 30 Capsules |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Pazinib contains Pazopanib 400mg, and is used to treat advanced kidney cancer (renal cell carcinoma) and certain types of soft tissue sarcoma in adults who have received prior chemotherapy.
| Composition | Pazopanib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | Kidney Cancer |
| Expiry | December 2027 |
Pemetero 500 mg Injection contains Pemetrexed, an anti-cancer medication used primarily to treat non-small cell lung cancer(NSCLC) and malignant pleural mesothelioma.
| Composition | Pemetrexed |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 1 Injection in 1 Vial |
| Prescribed For | Lung Cancer |
| Expiry | December 2027 |
Piclib contains Palbociclib 125 mg, a targeted therapy used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer.
| Composition | Palbociclib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 21 Capsules in 1 Bottle |
| Prescribed For | Metastatic Breast Cancer |
| Expiry | December 2027 |
Rompag contains Eltrombopag 25mg, a thrombopoietin receptor agonist used to treat low platelet counts in patients with conditions like chronic immune thrombocytopenia (ITP), aplastic anemia, or hepatitis C-associated thrombocytopenia.
| Composition | Eltrombopag |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 28 Tablets |
| Prescribed For | Chronic Immune Thrombocytopenia |
| Expiry | December 2027 |
Tafero EM Tablet is a combination of Tenofovir Alafenamide 25 mg and Emtricitabine 200 mg, used for the treatment and prevention of HIV-1 infection.
| Composition | Tenofovir Alafenamide 25 mg + Emtricitabine (200 mg) |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Tenof EM Tablet contains two antiretroviral medicines: emtricitabine (200 mg) and tenofovir disoproxil fumarate (300 mg), and it is used to treat and prevent HIV-1 infection in adults and teenagers.
| Composition | Emtricitabine (200 mg) and Tenofovir Disoproxil Fumarate (300 mg) |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Velasof 400 mg/100 mg Tablet is a fixed-dose combination of Sofosbuvir (400 mg) and Velpatasvir (100 mg), used to treat chronic hepatitis C virus (HCV) infection in adults.
| Composition | Sofosbuvir 400 mg and Velpatasvir 100 mg |
| Manufacturer | Hetero Healthcare Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Enzana 40mg Capsule contains Enzalutamide, a medication used to treat prostate cancer that has spread or is resistant to standard hormone therapy.
| Composition | Enzalutamide |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 56 Capsules |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Dyronib 50 mg Tablet is an oral anti-cancer medication containing Dasatinib, a tyrosine kinase inhibitor used in the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) and acute lymphoblastic leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 60 Tablets |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
| Composition | Daclatasvir |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Cronivir 0.5 mg Tablet contains entecavir, an antiviral medication used to treat chronic hepatitis B virus (HBV) infection in adults. It works by blocking the virus from multiplying and lowering the amount of hepatitis B virus in the body.
| Composition | Entecavir |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 30 Tablets |
| Prescribed For | Hepatitis B Virus |
| Expiry | December 2027 |
Carbotero 450mg contains Carboplatin, a platinum-based chemotherapy drug. It is used to treat various types of cancer by damaging the DNA of cancer cells, preventing them from growing and dividing.
| Composition | Carboplatin |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 1 vial(s) of 45 ml |
| Prescribed For | Anticancer |
| Expiry | December 2027 |
Ahabir 500mg Tablet contains Abiraterone Acetate, a hormonal therapy used in the treatment of metastatic castration-resistant prostate cancer (mCRPC).
| Composition | Abiraterone Acetate |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 60 Tablets |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
